Sample collection system including valve assembly

Abstract
A biological sample collection system includes (i) a sample collection vessel having an opening for receiving a biological sample, (ii) a selectively movable valve comprising a core and a collar disposed about the core, and (iii) a sealing cap coupled to the collar and including a reagent chamber for storing a measure of sample preservation reagent. The sealing cap is configured to associate and form a fluid tight connection with the sample collection vessel. Associating the sealing cap with the sample collection vessel causes a physical rearrangement of the core relative to the collar such that a fluid vent associated with the core is placed into fluid communication with the reagent chamber, thereby permitting sample preservation reagent to pass from the regent chamber to the sample collection vessel.
Description
BACKGROUND
Technical Field

This disclosure generally relates to vials and vessels for collecting and storing biological samples. More specifically, the present disclosure relates to systems and kits for the collection and preservation of biological samples for future testing in a laboratory or other biological sample analysis facility.


Background and Relevant Art

Field collection of biological samples can provide scientists, physicians, geneticist, epidemiologists, or similar personnel with invaluable information. For example, access to a fresh sample of a patient's blood, purulent discharge, or sputum can help a physician or epidemiologist to isolate or identify a causative agent of infection. Similarly, a saliva sample can permit a scientist or geneticist access to the requisite nucleic acid for genetic sequencing, phylotyping, or other genetic-based studies. In the foregoing examples, in addition to many other situations, it is desirable to work with a fresh biological sample to ensure procurement of accurate results. However, isolation of the probative composition (e.g., nucleic acid, proteins, chemicals, etc.) often requires use of specialized equipment and often benefits from controlled laboratory conditions.


It can be inconvenient and sometimes improbable to require patients/individuals to travel to a biological sample collection center having the appropriate equipment and desirable controlled environment for sample preparation. Similarly, it may be difficult for personnel to directly access the patient/individual, particularly if the sample size is large and/or geographically diverse (e.g., as can be found in large genetic studies of thousands of individuals across an entire country, ethnic population, or geographic region). Further complicating this issue, it is often beneficial to immediately process any procured biological sample, and field personnel may be limited by lack of access to appropriate specialized equipment or to a controlled environment for high-fidelity sample processing.


Some biological sample collection devices and kits have addressed some of the foregoing issues. For example, some commercial kits provide a user with a vial for receiving a biological sample and a preservation reagent that can be added to the collected biological sample, acting to preserve elements within the biological sample (to a certain extent and for a period of time). However, implementations of self-collection systems often rely on inexperienced or untrained individuals to deposit the biological sample into the receiving vessel. This presents a number of problems, including, for example, technical training and precise measurements often required to properly preserve the biological sample for later processing. In the absence of such, it is important to provide a biological sample collection system that can be easily implemented by a novice user and which can preserve the received biological sample for later processing.


Accordingly, there are a number of disadvantages with biological sample collection and preservations systems that can be addressed.


BRIEF SUMMARY

Implementations of the present disclosure solve one or more of the foregoing or other problems in the art with kits, apparatuses, and methods for collecting and preserving a biological sample. In particular, one or more implementations can include a biological sample collection system—or a kit including the same—for collecting and preserving a biological sample.


In some embodiments, a biological sample collection system can include a sample collection vessel having an opening for receiving a biological sample, a selectively movable valve comprising a core and a collar disposed about the core that is configured to at least partially associate with the opening of the sample collection vessel, and a sealing cap configured to associate with the selectively movable valve and with the sample collection vessel. The sealing cap can include a reagent chamber for storing a measure of sample preservation reagent. Associating the sealing cap with the sample collection vessel causes a physical rearrangement of the core relative to the collar such that a fluid vent associated with the core is moved into fluid communication with the reagent chamber, thereby permitting sample preservation reagent to pass from the regent chamber to the sample collection vessel.


In other embodiments, a biological sample collection system can include a sample collection vessel having an opening for receiving a biological sample and a plug assembly. The plug assembly can include a post having a fluid vent that is configured to at least partially associate with the opening of the sample collection vessel and a plug associated with the post that obscures the fluid vent in a closed configuration of the plug assembly. The biological sample collection system can additionally include a sealing cap configured to associate with the plug assembly and with the sample collection vessel. The sealing cap can include a reagent chamber for storing a measure of sample preservation reagent. Associating the sealing cap with the sample collection vessel can cause a physical rearrangement of the plug assembly such that the plug is removed from association with the post, thereby permitting sample preservation reagent to pass from the regent chamber to the sample collection vessel.


The present disclosure also includes methods for collecting and preserving a biological sample. An exemplary method includes receiving a biological sample at a disclosed sample collection system and associating a sealing cap with the sample collection vessel, for example, to cause a selectively movable valve associated with the sealing cap to open and thereby release sample preservation reagent held within the sealing cap into the sample collection chamber or to cause the plug of a plug assembly to dislodge, thereby releasing reagent held within the sealing cap into the sample collection chamber.


Accordingly, systems, methods, and kits for collecting a biological sample are disclosed herein. This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the detailed description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an indication of the scope of the claimed subject matter.


Additional features and advantages of the disclosure will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by the practice of the disclosure. The features and advantages of the disclosure may be realized and obtained by means of the instruments and combinations particularly pointed out in the appended claims. These and other features of the present disclosure will become more fully apparent from the following description and appended claims or may be learned by the practice of the disclosure as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

In order to describe the manner in which the above recited and other advantages and features of the disclosure can be obtained, a more particular description of the disclosure briefly described above will be rendered by reference to specific embodiments thereof, which are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the disclosure and are not therefore to be considered to be limiting of its scope. The disclosure will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1A illustrates a perspective view of an unassembled three-dimensional model of an exemplary sample collection system with the depicted sealing cap unsecured from the sample collection vessel in accordance with one or more embodiments of the present disclosure.



FIG. 1B illustrates a cross-sectional view of an assembled three-dimensional model of the sample collection system of FIG. 1A with the depicted sealing cap secured to a sample collection vessel and the associated valve in a closed configuration in accordance with one or more embodiments of the present disclosure.



FIG. 2A illustrates a cross-sectional view of the selectively movable valve of FIG. 1B depicted in a closed configuration in accordance with one or more embodiments of the present disclosure.



FIG. 2B illustrates a cross-sectional view of the selectively movable valve of FIGS. 1B and 2A isolated away from other components of the sample collection system and depicted in a closed configuration in accordance with one or more embodiments of the present disclosure.



FIG. 2C illustrates a cross-sectional view of the selectively movable valve of FIGS. 1B and 2A isolated away from other components of the sample collection system and depicted in an open configuration in accordance with one or more embodiments of the present disclosure.



FIGS. 3A and 3B illustrate perspective views of a core component of a selectively movable valve in accordance with one or more embodiments of the present disclosure.



FIGS. 4A and 4B illustrate perspective views of a collar component of a selectively movable valve in accordance with one or more embodiments of the present disclosure.



FIG. 5A illustrates a cross-sectional view of an assembled three-dimensional model of another sample collection system with the depicted sealing cap secured to a sample collection vessel and the associated plug assembly in a closed configuration.



FIG. 5B is a zoomed view of a portion of the plug assembly and sealing cap as shown in FIG. 5A.



FIG. 6 illustrates a three-dimensional rendering of an exemplary plug.



FIGS. 7A and 7B illustrate perspective views of an exemplary post of a plug assembly.





DETAILED DESCRIPTION

Embodiments of the present disclosure address one or more problems in the art of systems, kits, and/or methods for collecting and preserving a biological sample. A biological sample can be collected and its contents evaluated for various reasons, including, for example, identifying or characterizing a causative agent of disease (e.g., for treatment of the affected individual, for epidemiological reasons, etc.) or for genetic analysis of a subject's nucleic acid (e.g., genetic phylotyping, gene expression studies, genome sequencing, etc.). In most instances, including within the foregoing examples, it is desirous that the fidelity of the biological sample be maintained so that it retains its probative value. However, collecting and preparing biological samples for analysis has traditionally been a complex endeavor for the skilled technician or specialized professional. This is problematic for obvious reasons, including the time and cost associated with individually collecting and transporting biological samples, particularly when the subjects reside in disparate rural locations and require service from personnel with the proper skill set to properly collect and preserve the biological sample.


Embodiments of the present disclosure provide sample collection and preservation systems and kits, and methods for using the same, which address one or more of the foregoing problems. For example, utilizing systems, kits, and methods for collecting and preserving biological samples, as disclosed herein, removes the need of specialized personnel when collecting and initially preserving a biological sample. Furthermore, the disclosed embodiments simplify sample collection and preservation, which decreases the likelihood that even an unskilled user will err when collecting and preserving a biological sample.


As an illustrative example of the foregoing, biological sample collection kits disclosed herein include at least a two-piece sample collection and preservation system. A first portion includes a sample collection vessel or vessel, which can be detachably associated with a funnel. When used, the funnel acts to guide the receipt of a biological sample from a user into the sample collection chamber of the collection vessel or vessel. The funnel can also make it easier for a user to engage the collection vessel and deposit a biological sample into the sample collection chamber. After depositing the requisite amount of biological sample (which may be indicated by a mark on the sample collection vessel), a user can remove the funnel (if used) and associate the second portion of the two-piece sample preservation system—e.g., a sealing cap associated with a selectively movable valve or plug assembly—with the collection vessel. The reagent chamber of the sealing cap is pre-filled with a predetermined amount of sample preservation reagent, and as the sealing cap is drawn down to seal the received biological sample within the sample collection chamber of the collection vessel, the selectively movable valve or plug assembly enters an open configuration and the preservation reagent is released from the reagent chamber, through fluid vents in the valve core or plug assembly post, and into the sample collection chamber where it mixes with and preserves the received biological sample.


As described in more detail below, the selectively movable valves and valve assemblies can independently be opened (depending on the embodiment incorporating the same) to release reagents from the reagent chamber into the sample collection chamber.


With respect to embodiments having a selectively movable valve, the collar of the selectively movable valve is mechanically interlocked (e.g., via a friction fit) with the sealing cap such that the collar moves in unison with the sealing cap. The collar can be annular and surround the valve core forming a fluid tight connection therebetween. A flange associated with the core is sized and shaped to fit over the opening of the sample collection vessel (or structure associated therewith), preventing its ingress into the sample collection chamber. Upon association of the sealing cap with the sample collection vessel, the core flange abuts the opening of the sample collection chamber. As the sealing cap is further secured to the sample collection vessel (e.g., by threaded engagement), the collar moves in conjunction with the sealing cap, and the core remains stationary in relation to the sample collection vessel. In this way, the core moves (e.g., translates longitudinally) relative to the collar and sealing cap, causing the selectively movable valve to open (e.g., by undergoing a physical rearrangement). The independent movement of core relative to the sealing cap can be enabled by, for example, the force (e.g., frictional force or force required to overcome a mechanical interlock) between the core and the collar (which forms a fluid tight connection) being less than the force between the attachment mechanisms of the sealing cap and sample collection device. When moved to an open configuration, the previously obstructed fluid vents provided by the core are at least partially unobstructed, thereby creating a conduit for communicating the sample preservation solution from the reagent chamber of the sealing cap into to the sample collection chamber.


It should be appreciated that in some embodiments, opening of the selectively movable valve is reversible. That is, the selectively movable valve can be moved from an open configuration to a closed configuration. For example, embodiments of the disclosed apparatus can be configured so that the core can be manually repositioned within the collar (e.g., by applying a longitudinal force against the head member of the core and toward the collar), thereby returning the selectively movable valve to the closed configuration.


With respect to embodiments having a plug assembly, a collar of the plug assembly is mechanically interlocked (e.g., via a friction fit) with the sealing cap such that the collar moves in unison with the sealing cap. The collar can be annular and surround the post of the plug assembly and may form a fluid tight connection therebetween. Additionally, or alternatively, a plug can be positioned within the aperture formed by the collar, forming a fluid tight connection therebetween. The plug can have a head sized and shaped to overlay a portion of the top surface of the collar (forming a fluid tight connection therebetween) and/or can have a plug body sized and shaped to fit within the aperture formed by the collar such that a fluid tight connection is formed between the plug body and a sidewall of the collar (e.g., a sidewall defining the aperture). A flange associated with the post is sized and shaped to fit over the opening of the sample collection vessel (or structure associated therewith), preventing its ingress into the sample collection chamber. Upon association of the sealing cap with the sample collection vessel, the post flange abuts the opening of the sample collection chamber. As the sealing cap is further secured to the sample collection vessel (e.g., by threaded engagement), the collar moves in conjunction with the sealing cap, and the post remains stationary. In this way, the post moves (e.g., translates longitudinally) relative to the collar and sealing cap, causing the post to abut against and apply pressure to the plug, eventually causing the plug to dislodge from the collar and enter into the reagent chamber. The independent movement of post relative to the sealing cap can be enabled by, for example, the force (e.g., frictional force or force required to overcome a mechanical interlock) between the post and the collar and/or plug (which forms a fluid tight connection) being less than the force between the attachment mechanisms of the sealing cap and sample collection device. When moved to an open configuration, the previously obstructed fluid vent formed by the post is at least partially unobstructed, thereby creating a conduit for communicating the sample preservation solution from the reagent chamber of the sealing cap into to the sample collection chamber.


As can be appreciated from the foregoing, in addition to alternative and/or additional embodiments provided herein, the systems, kits, and methods of the present disclosure can be used by skilled or unskilled individuals with reduced likelihood of error associated with collecting and at least initially preserving a biological sample. Accordingly, implementations of the present disclosure can reduce the cost associated with procuring biological samples for diagnostic, scientific, or other purposes and can increase the geographic reach of potential sample collection areas without the need of establishing the necessary infrastructure (e.g., controlled environments conducive to sample collection and preservation, skilled personnel to physically collect, transport, and/or preserve the biological samples, etc.).


As used herein, the term “biological sample” can include any cell, tissue, or secretory fluid (whether host or pathogen related) that can be used for diagnostic, prognostic, genetic, or other scientific analysis. This can include, for example, a human cell sample such as skin. It can also include a non-human cell sample that includes any of a bacterium, virus, protozoa, fungus, parasite, and/or other prokaryotic or eukaryotic symbiont, pathogen, or environmental organism. The term “biological sample” is also understood to include fluid samples such as blood, urine, saliva, and cerebrospinal fluid and extends to other biological samples including, for example, mucus from the nasopharyngeal region and the lower respiratory tract (i.e., sputum).


As used herein, the “probative component” of the biological sample refers generally to any protein, nucleic acid, surface moiety, or other compound that can be isolated from the biological sample. Preferably, the probative component is or includes nucleic acid, more preferably DNA. In a preferred embodiment, the biological sample is or includes saliva, which presumptively contains a preferable probative component in the form of the user's genetic material (e.g., DNA and RNA).


Sample Collection Systems and Kits Having a Selectively Movable Valve


In one embodiment, a biological sample is collected, preserved, and stored in a collection vessel as part of a multi-piece sample collection system or kit. An example of a sample collection device similar to the embodiment illustrated in FIGS. 1-4 is set forth in U.S. Design application No. 29/698,615, filed Jul. 18, 2019, which is incorporated by reference. An example of a sample collection device similar to the embodiment illustrated in FIGS. 5-7 is set forth in U.S. Design application No. 29/698,614, filed Jul. 18, 2019, which is incorporated by reference.


As shown in FIG. 1A, a first piece of the system 100 or kit can include a sample collection vessel 102, a second piece includes a sample collection funnel (not shown), which may be packaged separately from or removably connected to the collection vessel, and a third piece includes a sealing cap 110 having a reagent chamber disposed within or integrated with the sealing cap selectively and a selectively movable valve comprised of a core and a collar. The sealing cap 110 is configured to associate with the sample collection vessel 102, to dispense sample preservation reagents into the sample collection vessel 102 through the selectively movable valve, and to seal the contents of the sample collection chamber therein.


For example, FIG. 1B illustrates a cross-sectional view of an assembled three-dimensional model of the sample collection system 100 of FIG. 1A. The system 100 includes a sample collection vessel 102 and optionally, a funnel (not shown), which can be associated with a top portion or opening 105 of the sample collection vessel 102 and thereby allow fluid communication with the sample collection chamber 103 of the sample collection vessel 102. The biological sample collection system 100 can also include a selectively movable valve 104 comprised of a core 106 and a collar 108 associated with the sealing cap 110 that has a reagent chamber 111 disposed within or integrated with the sealing cap 110. The sealing cap 110—together with the selectively movable valve 104—can be sized and shaped to associate with a top portion of the collection vessel 102 such that the cap 110 fits over and seals an opening 105 of the sample collection chamber 103 and at least a portion of the valve 104 (e.g., a flange 107 of the core 106) extends over the opening 105 of the sample collection chamber 103.


In some embodiments, the reagent within the reagent chamber 111 includes a preservation or buffering solution that protects the integrity of the probative component of the biological sample prior to purification or testing. Examples of preservation reagents that can be used in conjunction with the sample collection systems described herein are disclosed in U.S. Pat. No. 10,174,362, US Pat. Pub. No. 2019/0062806, and WO 2020/102570, which are incorporated by reference. Preservation reagents are typically chemical solutions and may contain one or more salts (e.g., NaCl, KCl, Na2HPO4, KH2PO4, or similar, and which may, in some implementations, be combined as a phosphate buffered saline solution, as known in the art), lysing agents (e.g., detergents such as Triton X-100 or similar), chelating agents (e.g., ethylenediaminetetraacetic acid (EDTA), ethylene glycol-bis(R-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA), or similar), distilled water, or other reagents known in the art.


In one or more embodiments, the reagent or buffering solution stabilizes at least one probative component within the sample (e.g., nucleic acids, such as DNA and RNA, protein, etc., and combinations thereof) during transfer, transportation, and/or storage at a laboratory, clinic, or other destination. After the preservation solution is added, the sample can be stored at or below room temperature for weeks or months without significant loss of the probative component. That is, the sample can still be utilized for diagnostic, genetic, epidemiologic, or other purposes for which it was collected after storage for weeks or months in the preservation solution.


With continued reference to FIG. 1, the sealing cap 110 and a saliva funnel (not shown) can each independently attach to the sample collection vessel 102 using a connection mechanism. The connection mechanism can include, for example, threads, snap or press fit connections, tongue and groove members, bayonet connection, or other interlocking or mechanically coupling mechanisms. For example, a funnel can be first attached to the sample collection vessel 102 via complementary connection mechanisms (e.g., complementary threads; not shown). After facilitating receipt of a biological sample from a user, the funnel can be removed by reversing the complementary connection mechanism (e.g., unscrewing the funnel; not shown), and a sealing cap 110 can be secured to the collection vessel 102 using a same or similar complementary connection mechanism. For example, as shown in FIGS. 1A and 1, the sealing cap 110 can include connection members 112 (e.g., threads) located on an inner circumferential wall of the sealing cap 110 that are complementary to and work in conjunction with the connection members 114 (e.g., complementary threads) disposed on an exterior surface of the sample collection vessel 102.


In some embodiments, the connection mechanism between the funnel and collection vessel is different than the connection mechanism between the solution cap and the collection vessel. For example, the funnel may be press fit or snap fit onto the collection vessel, whereas the solution cap is rotationally secured through engagement of complementary threads located on an exterior portion of the collection vessel and an interior portion of the solution cap or vice versa. Regardless of the attachment mechanism used, a sample preservation fluid can be introduced into the sample collection chamber 103 and mixed with the deposited biological sample as a result of the sealing cap 110 being attached to the sample collection vessel 102. As provided earlier, this can be due to the selectively movable valve 104 opening and allowing reagent to be released through fluid vent 116 defined by the open valve 104 and into the sample collection chamber 103.


The sealing cap 110 is configured to receive a measure of reagents into the reagent chamber 111, and as shown by the cross-sectional views of the assembled sample collection system 100 in FIG. 1B, a selectively movable valve 104 is associated with the sealing cap 110. The collar 108 can be snap-fittingly received into the sealing cap 110, creating a fluid tight connection therebetween. As illustrated, the collar 108 includes a retaining ring or flange that engages the sealing cap 110 to stabilize the collar 108.


As further illustrated by FIGS. 2A-2C, the core 106 defines a fluid vent 116, and when the valve 104 is in a closed configuration (as shown in FIGS. 2A and 2B), any reagent disposed within the reagent chamber 111 is retained and sealed within the reagent chamber 111. The valve 104 is shown in FIGS. 1B, 2A, and 2B as being aligned in a closed configuration. However, as shown in FIG. 2C, the selectively movable valve 104 can be arranged in an open configuration. When associated with the sealing cap 110 in an open configuration, reagent may be transferred from the reagent chamber 111 to the sample collection chamber 103 through the vent(s) 116.


That is, the fluid vent(s) 116 can be obstructed by the collar 108 of the selectively movable valve 104 when the valve 104 is in a closed configuration, as illustrated in FIGS. 2A and 2B. In this state, the interaction between the interior sidewall of the collar 108 and the head member 109 of the core 106 creates a fluid tight connection—at least at and/or around the fluid vent 116. The fluid tight connection between the collar 108 and the core 106 prevents the premature or unintentional expulsion of reagent from the reagent chamber 111.


It should be appreciated that in some embodiments, the fluid vent(s) and/or structure of the core can beneficially act as an agitator of fluids entering and/or traversing between the sample collection chamber and the sealing cap.


As the complementary threads 114, 112 between the sealing cap 110 and the sample collection vessel 102 are inter-engaged and the sealing cap 110 is advanced towards the sample collection vessel 102, the proximal flange 107 of the core 106 engages the upper lip of the sample collection tube defining the opening 105 thereof. As the sealing cap 110 is further secured to and moved toward the sample collection vessel 102 (e.g., by threaded engagement), the collar 108 moves in conjunction with the sealing cap 110, and the core 106 remains stationary relative to the sample collection vessel 102. In this way, the collar 108 is displaced longitudinally relative to the core 106, causing the selectively movable valve assembly 104 to enter an open configuration (e.g., by undergoing a physical rearrangement as shown in FIG. 2C). When moved to the open configuration, the previously obstructed fluid channels or vents 116 formed within the core 106 allow fluid communication between the reagent chamber 111 and the sample collection chamber 103.


The fluid channels/vents 116 formed within the core 106, and the various other components of the core 106 discussed above are illustrated in the perspective views of an exemplary core 106 in FIGS. 3A and 3B. Similarly, the collar 108 of FIGS. 1 and 2 is illustrated in multiple perspective views comprising FIGS. 4A and 4B.


As the core 106 transitions from the closed configuration to the open configuration, an annular retention element 113 disposed on the body of the core 106 forms a fluid tight seal with the inner sidewall of the collar 108. Upon fully entering the open configuration, the annular retention element 113 is flush with the top surface of the collar 108 and maintains a fluid-tight connection therebetween. Accordingly, there is no pooling of sample preservation reagent (from the fluid chamber) between the interior sidewall of the collar 108 and the exterior sidewall of the core 106. Instead, the sample preservation reagent is directed from the reagent chamber 111, through the fluid vents 116 formed within the core 106, and into the sample collection chamber 103 it mixes with and preserves the received biological sample. In this way, the valve assembly 104 can move from a closed configuration to an open configuration when the sealing cap 110 is sealed onto the sample collection vessel 102.


In some embodiments, the resistive force derived from the engagement of the collar 108 with the chamber sidewall is the result of an interference fit formed between the collar 108 and the chamber sidewall. The interference fit can, in some embodiments, be a fluid-tight fit.


In some embodiments, the rotational distance required to open the selectively movable valve 104 is proportional to the distance required to at least partially unobstruct the fluid vent 116. This distance may be the same or less than the distance traversed by the sealing cap 110 from initial engagement of the connection members 114, 112 to a sealed position of the cap 110 and vessel 102. However, it should be appreciated that although a plurality of fluid vents 116 are illustrated in the Figures, in some embodiments there can be fewer (e.g., a single fluid channel/vent or more than four fluid channels/vents).


Sample Collection Systems and Kits Having a Plug Assembly


Referring now to FIGS. 5-7, some sample collection systems can include a plug assembly. As shown, the hollow collar 202 of the plug assembly is mechanically interlocked (e.g., via a friction fit) with the sealing cap 210 such that the hollow collar 202 moves in unison with the sealing cap 210 toward the sample collection vessel 201 when the sealing cap 210 is used to seal the sample collection vessel 201. As shown in FIGS. 5A, 5B, and 6, the plug 204 includes a cylindrical body and two flanges. An upper flange 205 is sized and shaped to span the aperture formed by the hollow collar 202 and can, as shown, extend beyond the diameter of the collar's aperture such that a bottom surface of the upper flange 205 can form a fluid tight seal with the upper surface of the hollow collar 202. A lower flange 207 of the plug 204 extends radially from the cylindrical body and is sized and shaped to engage the sidewall of the hollow collar 202 defining the aperture.


The post 206 defines a plurality of fluid vents 212 that pass uninterrupted through the body of the post 206. A cylindrical upper portion of the post is sized and shaped to fit within the aperture defined by the hollow collar 202. A leading edge 208 of the upper portion of the post 206 is configured to associate with a bottom surface (e.g., the lower flange 207) of the plug 204. In the embodiment shown in FIGS. 5A and 5B, the leading edge 208 of the upper portion includes a crown that engages an indent formed within the bottom portion of the plug 204. In some embodiments, the outer rim of the crown is sized and shaped to engage the lower flange 207 of the plug 204. The post 206 additionally includes a base portion or flange 209 that is sized and shaped to engage the opening of the sample collection vessel (or structure associated therewith).


When provided to a user for collecting a biological sample (typically saliva), the plug-disc device (e.g., device 200) is included in two parts: (1) the sample collection vessel 201 and (2) the sealing cap 210, which includes the seal assembly (in a sealed configuration) forming a fluid-tight seal over the reagent chamber where it retains preloaded sample preservation solution. The user can deposit the biological sample within the sample collection tube, and following use, the sealing cap is associated with the sample collection tube to seal the received biological sample.


Upon association of the sealing cap 210 with the sample collection vessel 201, the base portion or flange 209 of the post 206 engages the upper lip of the sample collection vessel defining the opening thereof. As the sealing cap 210 is further secured to and moved toward the sample collection vessel 201 (e.g., by threaded engagement), the hollow collar 202 moves in conjunction with the sealing cap 210, and the post 206 remains stationary relative to the sample collection vessel 201. In this way, the hollow collar 202 is displaced longitudinally with respect to the post 206, and this causes the leading edge 208 (e.g., crown portion) of the post 206 to press against the bottom side (e.g., lower flange 207) of the plug 204. At some point, the rotational force of tightening the sealing cap 210 is translated into a force sufficient to cause the plug 204 to disengage from the hollow collar 202. At first, the upper flange 205 is translated away from the hollow collar 202, thereby breaking the fluid-tight seal formed therebetween, while the second, lower flange 207 remains in contact with the sidewall of the hollow collar 202. Eventually, however, the post 206 presses—and moves—the plug 204 such that the lower flange 207 becomes disengaged from the sidewall, causing the plug 204 to be ejected into the reagent chamber of the sealing cap 210.


Once the plug 204 is disengaged from the hollow collar 202, the upper end of the post 206 is brought into fluid communication with the reagent chamber—essentially converting the seal assembly to an unsealed configuration. In this unsealed configuration, the fluid vents 212 are unobstructed and act as channels for transporting the sample preservation solution from the reagent chamber to the sample collection vessel 201. The body of the post 206 forms a fluid tight seal with the inner sidewall of the hollow collar 202, forcing egress of sample preservation solution through the fluid vents/channels 212. Accordingly, there is no pooling of sample preservation reagent (from the reagent chamber) between the interior sidewall of the hollow collar 202 and the exterior sidewall of the post 206. Instead, the sample preservation reagent is directed from the reagent chamber, through the fluid vents 212 formed within the post 206, and into the sample collection vessel 201 where it mixes with and preserves the received biological sample. In this way, the seal assembly can move from a sealed configuration to an unsealed configuration when the sealing cap 210 is sealed onto the sample collection vessel 201.


In some embodiments, the seal assembly can be reversibly sealed and unsealed. That is, the plug 204 from the seal assembly can be serially added and removed from the opening of the hollow collar 202 to iterate from the sealed configuration to the unsealed configuration. For example, associating the sealing cap 210 with the sample collection vessel 201 can cause the plug 204 to disengage, thereby causing the seal assembly to transition from the sealed configuration to the unsealed configuration. In the unsealed configuration, the post 206 can be retracted and the plug 204 again placed within the hollow collar 202 to transition the seal assembly from the unsealed configuration to the sealed configuration.


Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present disclosure pertains.


It will also be appreciated that systems, devices, products, kits, methods, and/or processes, according to certain embodiments of the present disclosure may include, incorporate, or otherwise comprise properties, features (e.g., components, members, elements, parts, and/or portions) described in other embodiments disclosed and/or described herein. Accordingly, the various features of certain embodiments can be compatible with, combined with, included in, and/or incorporated into other embodiments of the present disclosure. Thus, disclosure of certain features relative to a specific embodiment of the present disclosure should not be construed as limiting application or inclusion of said features to the specific embodiment. Rather, it will be appreciated that other embodiments can also include said features, members, elements, parts, and/or portions without necessarily departing from the scope of the present disclosure.


Moreover, unless a feature is described as requiring another feature in combination therewith, any feature herein may be combined with any other feature of a same or different embodiment disclosed herein. Furthermore, various well-known aspects of illustrative systems, methods, apparatus, and the like are not described herein in particular detail in order to avoid obscuring aspects of the example embodiments. Such aspects are, however, also contemplated herein.


The present disclosure may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. While certain embodiments and details have been included herein and in the attached disclosure for purposes of illustrating embodiments of the present disclosure, it will be apparent to those skilled in the art that various changes in the methods, products, devices, and apparatus disclosed herein may be made without departing from the scope of the disclosure or of the invention, which is defined in the appended claims. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A biological sample collection system, comprising: a sample collection vessel having an opening for receiving a biological sample;a selectively movable valve configured to associate with the sample collection vessel and comprising: a core including a fluid vent and a flange configured to limit advancement of the core through the opening of sample collection vessel; anda collar non-threadedly disposed about the core and forming a fluid-tight seal with the core and obstructing the fluid vent; anda sealing cap coupled to the collar, the sealing cap comprising a reagent chamber for storing a sample preservation reagent and being configured to removably associate with and form a fluid tight connection with the sample collection vessel, wherein the selectively moveable valve is configured to seal the reagent chamber while the fluid vent is obstructed,wherein associating the sealing cap with the sample collection vessel causes a physical rearrangement of the selectively movable valve via movement of the core relative to the collar such that the fluid vent of the core is placed in fluid communication with the reagent chamber, thereby establishing fluid communication between the reagent chamber and the sample collection vessel.
  • 2. The biological sample collection system of claim 1, wherein the physical rearrangement of the selectively movable valve comprises translational movement of the collar relative to the core along a longitudinal axis and in unison with the sealing cap when associating the sealing cap with the sample collection vessel.
  • 3. The biological sample collection system of claim 1, wherein the sample collection vessel further comprises a connection member.
  • 4. The biological sample collection system of claim 3, wherein the sealing cap comprises a complementary connection member configured to associate with the connection member of the sample collection vessel to couple the sample collection vessel and the sealing cap.
  • 5. The biological sample collection system of claim 4, wherein the connection member comprises a ridge projecting away from the sample collection vessel or a depression within the sample collection vessel and the complementary connection member comprises a depression or ridge sized and shaped to engage the connection member.
  • 6. The biological sample collection system of claim 4, wherein the connection member and the complementary connection member comprise threads.
  • 7. The biological sample collection system of claim 6, wherein the threads of the complementary connection member comprise internal threads of the sealing cap.
  • 8. The biological sample collection system of claim 1, wherein the sample collection system comprises a separable two-piece sample collection system, the sample collection vessel comprising a first piece of the separable two-piece sample collection system and the selectively movable valve and sealing cap comprising a second piece of the separable two-piece sample collection system.
  • 9. The biological sample collection system of claim 1, wherein the fluid vent associated with the core is obstructed by the collar when the selectively movable valve is in a closed configuration, and wherein the fluid vent is at least partially unobstructed by the collar when the selectively movable valve is placed in an open configuration upon associating the sealing cap with the sample collection vessel.
  • 10. The biological sample collection system of claim 9, wherein the core comprises a head member opposite the flange and configured to form a fluid-tight seal with the collar when the selectively movable valve is in the closed configuration.
  • 11. The biological sample collection system of claim 10, wherein the core comprises an annular retention element configured to maintain a fluid-tight seal with the collar when the selectively movable valve is in the open configuration.
  • 12. The biological sample collection system of claim 10, wherein a retention force between the head member and the collar is less than a mechanical force of associating the sealing cap with the sample collection vessel.
  • 13. The biological sample collection system of claim 10, wherein the flange is sized and shaped to prevent the core from traversing the opening of the sample collection vessel.
  • 14. The biological sample collection system of claim 1, wherein the core comprises a plurality of fluid vents.
  • 15. The biological sample collection system of claim 14, wherein the fluid vents are disposed radially about the core.
  • 16. The biological sample collection system of claim 14, wherein each fluid vent spans an interior portion of the core and is uninterrupted from an entrance aperture to an exit aperture.
  • 17. The biological sample collection system of claim 1, further comprising a sample preservation reagent in the reagent chamber.
  • 18. A kit for collecting and preserving a biological sample, comprising: a sample collection vessel comprising a sample collection chamber and an opening configured to receive the biological sample into the sample collection chamber; anda sealing cap configured to removably associate and form a fluid tight connection with the sample collection vessel, the sealing cap comprising: a reagent chamber configured to store therein a sample preservation reagent; anda selectively movable valve coupled to the sealing cap and configured to retain the sample preservation reagent in the reagent chamber when in a closed configuration, wherein the selectively movable valve is configured to associate with the sample collection vessel and comprises: a core defining one or more fluid vents and having a flange configured to limit advancement of the core through the opening of the sample collection vessel; anda collar non-threadedly associated with the core and forming a fluid-tight seal with the core and obstructing the one or more fluid vents when the selectively movable valve is in the closed configuration,wherein when the sealing cap is associated with the sample collection vessel and the selectively movable valve is moved into the open configuration by non-threaded movement of the collar relative to the core to at least partially unobstruct the one or more fluid vents, fluid communication from the reagent chamber to the sample collection vessel is enabled via the at least one fluid vent.
  • 19. The kit of claim 18, further comprising a funnel configured to associate with the sample collection vessel and guide a biological sample from a user into the sample collection chamber.
  • 20. A separable two-piece sample collection system, comprising: a first piece, comprising a sample collection vessel having an opening for receiving a biological sample; anda second piece, comprising a sealing cap coupled to a selectively movable valve, wherein the selectively movable valve comprises: a collar coupled to an interior portion of the sealing cap; anda core configured to form a fluid tight connection with the collar when the selectively movable valve is in a closed configuration and a flange configured to limit advancement of the core through the opening of sample collection vessel upon coupling the sealing cap to the sample collection vessel,wherein the core defines one or more fluid vents that are obstructed by the collar when the selectively movable valve is in the closed configuration and, by associating the sealing cap with the sample collection vessel, are at least partially unobstructed by the collar when the selectively movable valve is in an open configuration, wherein the one or more fluid vents are configured to permit a sample preservation reagent stored within a reagent chamber of the sealing cap to pass from the reagent chamber and into the sample collection vessel when the selectively movable valve is in the open configuration.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. patent application Ser. No. 18/204,120, filed May 31, 2023, which is a continuation of U.S. patent application Ser. No. 16/906,830, filed Jun. 19, 2020, which claims the benefit of U.S. Provisional Application No. 62/864,500, filed Jun. 20, 2019, which are incorporated by reference in their entirety.

US Referenced Citations (194)
Number Name Date Kind
2275567 Smith Mar 1942 A
2631521 Atkins, Jr. Mar 1953 A
2653611 Smith Sep 1953 A
2764983 Pius et al. Oct 1956 A
2773591 Jensen Dec 1956 A
3321097 Solowey May 1967 A
3340873 Solowey Sep 1967 A
3347410 Schwartzman Oct 1967 A
3441179 Ragan Apr 1969 A
3464414 Sponnoble Sep 1969 A
3518164 Andelin et al. Jun 1970 A
3536191 Williams Oct 1970 A
3537606 Solowey Nov 1970 A
3603484 Ogle Sep 1971 A
3651990 Cernei Mar 1972 A
3670914 Poulsen, Jr. Jun 1972 A
3674028 Ogle Jul 1972 A
3684455 Vacirca et al. Aug 1972 A
3731853 Beham et al. May 1973 A
3792699 Tobin et al. Feb 1974 A
3846077 Ohringer Nov 1974 A
3878571 Seeley Apr 1975 A
3924741 Kachur et al. Dec 1975 A
3968872 Cavazza Jul 1976 A
4102451 Clarke et al. Jul 1978 A
4150950 Takeguchi et al. Apr 1979 A
4195730 Hunt Apr 1980 A
4221291 Hunt Sep 1980 A
4311792 Avery Jan 1982 A
4324859 Saxholm Apr 1982 A
4418702 Brown et al. Dec 1983 A
4465183 Saito et al. Aug 1984 A
4473530 Villa-Real Sep 1984 A
4589548 Fay May 1986 A
4591050 Finke et al. May 1986 A
4615437 Finke et al. Oct 1986 A
4634003 Ueda et al. Jan 1987 A
4727985 McNeirney et al. Mar 1988 A
4741346 Wong et al. May 1988 A
4761379 Williams et al. Aug 1988 A
4920975 Fay May 1990 A
4932081 Burns Jun 1990 A
4982875 Pozzi et al. Jan 1991 A
5029718 Rizzardi Jul 1991 A
5119830 Davis Jun 1992 A
5128104 Murphy et al. Jul 1992 A
5152965 Fisk et al. Oct 1992 A
5266266 Nason Nov 1993 A
5268148 Seymour Dec 1993 A
5291991 Meyer Mar 1994 A
5330048 Haber et al. Jul 1994 A
5335673 Goldstein et al. Aug 1994 A
5422241 Goldrick et al. Jun 1995 A
5425921 Coakley et al. Jun 1995 A
5445965 Stone Aug 1995 A
5478722 Caldwell Dec 1995 A
5490971 Gifford et al. Feb 1996 A
5494646 Seymour Feb 1996 A
5643767 Fischetti et al. Jul 1997 A
5658531 Cope et al. Aug 1997 A
5714380 Neri et al. Feb 1998 A
5786228 Charlton Jul 1998 A
5827675 Skiffington et al. Oct 1998 A
5869328 Antoci et al. Feb 1999 A
5921396 Brown, Jr. Jul 1999 A
5927549 Wood Jul 1999 A
5935864 Schramm et al. Aug 1999 A
5941380 Rothman Aug 1999 A
5950819 Sellars Sep 1999 A
5967309 Robles-Gonzalez et al. Oct 1999 A
5968746 Schneider Oct 1999 A
5973137 Heath Oct 1999 A
5976829 Birnboim Nov 1999 A
5984141 Gibler Nov 1999 A
6003728 Elliott Dec 1999 A
6113257 Sharon et al. Sep 2000 A
6121055 Hargreaves Sep 2000 A
6138821 Hsu Oct 2000 A
6148996 Morini Nov 2000 A
6149866 Luotola et al. Nov 2000 A
6204375 Lader Mar 2001 B1
6224922 Fonte May 2001 B1
6228323 Asgharian et al. May 2001 B1
6277646 Guirguis et al. Aug 2001 B1
6309827 Goldstein et al. Oct 2001 B1
6503716 Lai et al. Jan 2003 B1
6524530 Igarashi et al. Feb 2003 B1
6527110 Moscovitz Mar 2003 B2
6528641 Lader Mar 2003 B2
6533113 Moscovitz Mar 2003 B2
6617170 Augello et al. Sep 2003 B2
6776959 Helftenbein Aug 2004 B1
7282371 Helftenbein Oct 2007 B2
7464811 Patterson et al. Dec 2008 B2
7482116 Birnboim Jan 2009 B2
7748550 Cho Jul 2010 B2
8084443 Fischer et al. Dec 2011 B2
8137958 Grimes et al. Mar 2012 B2
8293467 Fischer et al. Oct 2012 B2
8415330 Fischer et al. Apr 2013 B2
8418865 Cho Apr 2013 B2
8669240 Fischer et al. Mar 2014 B2
8728414 Beach et al. May 2014 B2
9079181 Curry et al. Jul 2015 B2
9138747 Williams et al. Sep 2015 B2
9212399 Fischer et al. Dec 2015 B2
9370775 Harvey et al. Jun 2016 B2
9442046 Biadillah et al. Sep 2016 B2
9523115 Birnboim Dec 2016 B2
9683256 Fischer et al. Jun 2017 B2
9732376 Oyler et al. Aug 2017 B2
10000795 Birnboim et al. Jun 2018 B2
10174362 Gaeta Jan 2019 B2
10189020 Williams et al. Jan 2019 B2
10525473 Williams Jan 2020 B2
10576468 Biadillah et al. Mar 2020 B2
10619187 Birnboim Apr 2020 B2
10767215 Birnboim et al. Sep 2020 B2
10774368 Gaeta Sep 2020 B2
11002646 Biadillah et al. May 2021 B2
20010023072 Crawford et al. Sep 2001 A1
20010031473 Dattagupta et al. Oct 2001 A1
20020110810 Shuber Aug 2002 A1
20020197631 Lawrence et al. Dec 2002 A1
20030086830 Haywood et al. May 2003 A1
20030114430 MacLeod et al. Jun 2003 A1
20030132244 Birkmayer et al. Jul 2003 A1
20030143752 Feldsine et al. Jul 2003 A1
20040014237 Sugiyama et al. Jan 2004 A1
20040038269 Birnboim Feb 2004 A1
20040038424 Maples Feb 2004 A1
20040101859 Moon et al. May 2004 A1
20040161788 Chen et al. Aug 2004 A1
20040200740 Cho Oct 2004 A1
20040200741 Cho Oct 2004 A1
20040237674 Wu et al. Dec 2004 A1
20050079484 Heineman et al. Apr 2005 A1
20050101920 Keane et al. May 2005 A1
20050112024 Guo et al. May 2005 A1
20050123928 Das et al. Jun 2005 A1
20060216196 Satoh et al. Sep 2006 A1
20060245977 Bodner Nov 2006 A1
20060260959 Patterson et al. Nov 2006 A1
20070072229 Bialozynski et al. Mar 2007 A1
20070134134 Watts et al. Jun 2007 A1
20070140915 Sakal et al. Jun 2007 A1
20070202511 Chen et al. Aug 2007 A1
20070280042 Yamanaka Dec 2007 A1
20070287149 Shomi et al. Dec 2007 A1
20080003574 Michalik et al. Jan 2008 A1
20080067084 Patterson et al. Mar 2008 A1
20080156674 Correale et al. Jul 2008 A1
20080187924 Korfhage et al. Aug 2008 A1
20080194986 Conway et al. Aug 2008 A1
20080226506 Ohashi Sep 2008 A1
20080260581 Rosman et al. Oct 2008 A1
20080293156 Smith Nov 2008 A1
20090022631 Ohashi et al. Jan 2009 A1
20090023219 Perez Jan 2009 A1
20090133366 Cronin et al. May 2009 A1
20090216213 Muir et al. Aug 2009 A1
20090312285 Fischer et al. Dec 2009 A1
20110068102 Porter Mar 2011 A1
20110212002 Curry et al. Sep 2011 A1
20120046574 Skakoon Feb 2012 A1
20120220043 Sangha Aug 2012 A1
20120308448 Wong Dec 2012 A1
20120325721 Plante et al. Dec 2012 A1
20130011311 Kim Jan 2013 A1
20130026691 Cahill et al. Jan 2013 A1
20130209993 Aronowitz Aug 2013 A1
20130248045 Williams et al. Sep 2013 A1
20140051178 Niggel et al. Feb 2014 A1
20140120531 Biadillah et al. May 2014 A1
20140242685 Knoppke et al. Aug 2014 A1
20150056716 Oyler et al. Feb 2015 A1
20150140681 Meng et al. May 2015 A1
20150190122 Butlin et al. Jul 2015 A1
20150203258 Staton Jul 2015 A1
20150289856 Saqi et al. Oct 2015 A1
20150343438 Williams et al. Dec 2015 A1
20160023210 Birkner et al. Jan 2016 A1
20160045187 Terbrueggen et al. Feb 2016 A1
20160296936 Trump et al. Oct 2016 A1
20170001191 Biadillah et al. Jan 2017 A1
20170350797 Estep et al. Dec 2017 A1
20180344568 Phillips et al. Dec 2018 A1
20190151842 Williams et al. May 2019 A1
20190200966 Zhan et al. Jul 2019 A1
20200156056 Williams et al. May 2020 A1
20200254460 Blair et al. Aug 2020 A1
20200269232 Williams et al. Aug 2020 A1
20200284704 Biadillah et al. Sep 2020 A1
20200398267 Biadillah et al. Dec 2020 A1
Foreign Referenced Citations (53)
Number Date Country
2013206564 Jul 2013 AU
2072331 Dec 1992 CA
2236240 Oct 1999 CA
2348152 Feb 2000 CA
2488769 Dec 2003 CA
101321586 Dec 2008 CN
103890163 Jun 2014 CN
106132456 Nov 2016 CN
106879252 Jun 2017 CN
10219117 Oct 2003 DE
0215533 Mar 1987 EP
0215735 Mar 1987 EP
0586024 Mar 1994 EP
0734684 Oct 1996 EP
1513952 Dec 2010 EP
1403274 Aug 1975 GB
05-187976 Jul 1993 JP
06-046856 Feb 1994 JP
09-509495 Sep 1997 JP
10-273161 Oct 1998 JP
2000-346838 Dec 2000 JP
2009-031300 Feb 2009 JP
2009-519439 May 2009 JP
2010-213660 Sep 2010 JP
2014-527615 Oct 2014 JP
2017-522550 Aug 2017 JP
2018-021916 Feb 2018 JP
10-2019-0019491 Feb 2019 KR
8906704 Jul 1989 WO
9102740 Mar 1991 WO
9705248 Feb 1997 WO
9748492 Dec 1997 WO
9803265 Jan 1998 WO
9804899 Feb 1998 WO
9838917 Sep 1998 WO
9844158 Oct 1998 WO
9929904 Jun 1999 WO
0006780 Feb 2000 WO
0010884 Mar 2000 WO
0077235 Dec 2000 WO
0134844 May 2001 WO
0288296 Nov 2002 WO
2003104251 Dec 2003 WO
2004017895 Mar 2004 WO
2004094635 Nov 2004 WO
2004104181 Dec 2004 WO
2005051775 Jun 2005 WO
2005111210 Nov 2005 WO
2005120977 Dec 2005 WO
2006096973 Sep 2006 WO
2012177656 Dec 2012 WO
2015112496 Jul 2015 WO
2019104215 May 2019 WO
Non-Patent Literature Citations (52)
Entry
463a. Edta-Medium, 2010 DSMZ Gmbh.
Ausubel et al. , “Analysis of Protein Interactions”, Current Protocols in Molecular Biology, Dec. 4, 2003.
Ausubel et al.,“Preparation and Analysis of RNA” Current Protocols in Molecular Biology, Dec. 4, 2003.
Boom et al., “Rapid and Simple Method for Purification of Nucleic Acids”, Journal of Clinical Microbiology, Apr. 1990.
Brady, Chapter 16 Acid-Base Equilibria in Aqueous Solutions, “General Chemistry Principles and Structure Buffers: the control of pH” 1990.
Breslow et al., “On the mechanism of action of ribonuclease A: Relevance of enzymatic studies with a p-nitrophenylphosphate ester and a thiophosphate ester” Proc. Natl. Acad. Sci. USA., vol. 93, pp. 10018-10021, Sep. 1996.
Chirgwin et al.“Isolation of Biologically Active Ribonucleic Acid from Sources Enriched in Ribonuclease”, Biochemistry vol. 18, No. 24, 1979.
Cox et al., “The Use of Guanidinium Chloride in the Isolation of Nucleic Acids” Methods in Enzymology, vol. XII, Nucleic Acids, Part B, 1968.
Cunningham et al., “Colorectal Cancer Methods and Protocols” Methods in Molecular Medicine, vol. 50; 2001.
Doosti et al., “Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran” Ann Clin Microbial Antimicrob. Jun. 5, 2014.
European Search Report received for EP Patent Application No. 19887385.3, mailed on Aug. 8, 2022, 10 pages.
European Search Report received for EP Patent Application No. 20826985.2, mailed on Aug. 30, 2023, 13 pages.
European Search Report received for EP Patent Application No. 20826985.2, mailed on May 30, 2023, 14 pages.
Excerpts from The American Heritage Dictionary, 2000.
Farrell, “RNA Methodologies a Laboratory Guide for Solation and Aracterization Chapters 4 and 5” Copyright Elsevier 2021.
Feramisco et al., “Co-existence of Vinculin and a Vinculin-like Protein of Higher Molecular Weight in Smooth Muscle” The Journal of Biological Chemistry, vol. 257, No. 18, Issue of Sep. 25, pp. 11024-11031, 1982.
Fisher Catalog 1998-1999.
Freeman et al., “DNA by Mail: An Inexpensive and Noninvasive Method for Collecting DNA Samples from Widely Dispersed Populations” Behavior Genetics, vol. 27, No. 3 1997.
Garcia-Closas et al., “Collection of Genomic DNA from Adults in Epidemiological Studies by Buccal Cytobrush and Mouthwash” Cancer Epidemiology, Biomarkers and Prevention, vol. 10, 687-696, Jun. 2001.
Goldenberger et al., “A Simple “Universal” DNA Extraction Procedure Using SOS and Proteinase K is Compatible with Direct PCR Amplification” PCR Methods and Applications, Received Dec. 12, 1997; accepted Mar. 31, 1995.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2019/062484, mailed on Jun. 3, 2021, 8 pages.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2020/038858, mailed on Dec. 30, 2021, 9 pages.
International Search Report and Written Opinion issued in PCT/US19/62484 dated Jan. 29, 2020.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US20/038858, mailed on Sep. 30, 2020, 11 pages.
International Search Report issued in PCT/US2018/030681 dated Jul. 12, 2018.
Jennings et. al., Petition for Inter Partes Review of U.S. Pat. No. 11,002,646, Jul. 29, 2022.
Johnson et al., “Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands”, Infect Control Hosp Epidemiol, Jun. 2010.
Kilpatrick et al, “Noncryogenic Preservation of Mammalian Tissues for DNA Extraction: An Assessment of Storage Methods” Biochemical Genetics, vol. 40, Nos. ½, Feb. 2002.
Loens et al., “Detection of Mycoplasma pneumoniae in Spiked Clinical Samples by Nucleic Acid Sequence-Based Amplification” Journal of Clinical Microbiology, Apr. 2002, p. 1339-1345.
Longmire et al., “Use of “Lysis Buffer” in DNA Isolation and its Implication for Museum Collections” Museum of Texas Tech University, No. 163, May 1, 1997.
Maniatis et al., “Isolation of MRNA From Mammalian Cells”, 1982.
Maniatis et al., “Molecular Cloning a Laboratory Manual” Cold Spring Harbor Laboratory; 1982.
Meulenbelt et al., “High-Yield Noninvasive Human Genomic DNA Isolation Method for Genetic Studies in Geographically Dispersed Families and Populations” 1995.
Monahan et al., “Extraction of RNA from Intracellular Mycobacterium tuberculosis” Methods in Molecular Medicine, vol. 54: Mycobacterium tuberculosis Protocols; 2001.
Noll et al., “The Use of Sodium and Lithium Dodecyl Sulfate in Nucleic Acid Isolation” Methods in Enzymology, vol. XII, Nucleic Acids, Part B, 1968.
Piotr Chomczynsk, et al., “Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction” Analytical Biochemistry 162, 156-159; 1987.
Promega 1993-1994 Catalog, Revolutions in Science.
Rutala et al., “Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008”.
Rymaszewski et al., “Estimation of cellular DNA content in cell lysates suitable for RNA isolation” Analytical Biochemistry, vol. 188, Issue 1, Jul. 1990, pp. 91-96.
Sela et al., “The Correlation of Ribonuclease Activity with Specific Aspects of Tertiary Structure” Biochimica et Biophysica Acta, vol. 26, 1957.
Seutin et al., “Preservation of avian blood and tissue samples for DNA analyses” 1990.
Shahbazi et al., “Screening of SOS-degrading bacteria from car wash wastewater and study of the alkylsulfatase enzyme activity”, Iranian Journal of Microbiology, vol. 5 No. 2, Jun. 2013, pp. 153-158.
Spectrum Solutions, “FDA Emergency Use Authorization Granted Utilizing Saliva for COVID-19 Testing Exlcusively Using SDNA-1000Saliva Collection Device from Spectrum” Apr. 13, 2020.
Spectrum Solutions, “Technically Superior Whole Saliva Collection Devices, accessed on Nov. 20, 2020”.
Streckfus et al., “Saliva as a diagnostic fluid” 2002.
Tabak et al., “A Revolution in Biomedical Assessment: The Development of Salivary Diagnostics” Journal of Dental Education, Dec. 2001.
Thermo Fisher Scientific, “Top 10 Ways to Improve Your RNA Isolation”, Downloaded on or around Nov. 22, 2021.
Vintiloiu et al., “Effect of ethylenediaminetetraacetic acid (EDTA) on the bioavailability of trace elements during anaerobic digestion” Chemical Engineering Journal, vol. 223, May 1, 2013, pp. 436-441.
Woldringh et al., “Effects of Treatment with Sodium Dodecyl Sulfate on the Ultrastructure of Escherichia coli” Journal of Bacteriology, Sep. 1972.
Yuan et al., “Statistical Analysis of Real-Time PCR Data” BMC Bioinformatics, Feb. 22, 2006.
Zou, “A Practical Approach to Genetic Screening for Influenza Virus Variants”, Journal of Clinical Microbiology, vol. 25, No. 10, Oct. 1997, p. 2623-2627.
Lin, “Chemical plant sampling system design”, Shandong chemical industry, vol. 43, No. 8, Dec. 31, 2014, pp. 149-151.
Related Publications (1)
Number Date Country
20230338013 A1 Oct 2023 US
Provisional Applications (1)
Number Date Country
62864500 Jun 2019 US
Continuations (2)
Number Date Country
Parent 18204120 May 2023 US
Child 18208980 US
Parent 16906830 Jun 2020 US
Child 18204120 US